Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Conversion of 5,659,999 GRAF shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Graf Global Corp. (GRAF) | Conversion | 5,659,999 | n/a |
| Dec 27, 2024 | NKGen Biotech, Inc. (NKGN) | Other (see footnotes) | 63,634 | n/a |
| Dec 23, 2024 | NKGen Biotech, Inc. (NKGN) | Other (see footnotes) | 97,232 | n/a |
| Dec 11, 2024 | NKGen Biotech, Inc. (NKGN) | Grant/Award | 500,000 | n/a |
| Dec 5, 2023 | NKGen Biotech, Inc. (NKGN) | Purchase | 220 | $737.00 |
| Nov 22, 2023 | NKGen Biotech, Inc. (NKGN) | Purchase | 10 | $29.40 |
| Oct 4, 2023 | NKGen Biotech, Inc. (NKGN) | Other (see footnotes) | 1,773,631 | n/a |
| Jul 14, 2021 | Graf Acquisition Corp. IV (GFOR) | Other (see footnotes) | 20,000 | n/a |
| Jun 3, 2021 | Graf Acquisition Corp. IV (GFOR) | Purchase | 1,818 | $18.0K |
| Jun 2, 2021 | Graf Acquisition Corp. IV (GFOR) | Other (see footnotes) | 22,125 | n/a |